Table 4:
Prevalence of polysubstance exposure among mothers testing positive for short acting (SAO, n = 126) and long acting (LAO, n = 71) opioids
| Polysubstance exposure within opioid subtypes | ||
|---|---|---|
| Primary substance (n) | Additional substances (n) | % Primary |
| SAO (126) | Nicotine (78) | 61.9 |
| SAO (126) | Nicotine and another substance (49) | 38.9 |
| SAO (126) | THC (21) | 16.7 |
| SAO (126) | Cocaine (25) | 19.8 |
| SAO (126) | Methamphetamine (22) | 17.5 |
| SAO (126) | Methamphetamine and cocaine (16) | 12.7 |
| SAO (126) | Benzodiazepines (8) | 6.3 |
| SAO (126) | Methamphetamine and THC (6) | 4.8 |
| SAO (126) | THC and cocaine (5) | 4.0 |
| SAO (126) | THC, cocaine, and methamphetamine (4) | 3.2 |
| SAO (126) | Methamphetamine and benzodiazepines (2) | 1.6 |
| LAO (71) | Nicotine (66) | 93.0 |
| LAO (71) | Nicotine and another substance (28) | 39.4 |
| LAO (71) | Fentanyl (10) | 14.1 |
| LAO (71) | Methamphetamine (10) | 14.1 |
| LAO (71) | Cocaine (9) | 12.7 |
| LAO (71) | THC (9) | 12.7 |
| LAO (71) | Morphine (7) | 9.9 |
| LAO (71) | Fentanyl and methamphetamine (6) | 8.5 |
| LAO (71) | Hydromorphone (3) | 4.2 |
| LAO (71) | Benzodiazepines (3) | 4.2 |
| LAO (71) | Naloxone (3) | 4.2 |
| LAO (71) | Oxycodone (3) | 4.2 |
| LAO (71) | Tramadol (2) | 2.8 |